Sirolimus-Eluting Stents at Two Years: A Pooled Analysis of SIRIUS, E-SIRIUS, and C-SIRIUS With Emphasis on Late Revascularizations and Stent Thromboses

American Journal of Cardiology

Volumn 98, Issue 1, 2006, Pages 36-41

  Schampaert, Erick ^a   Moses, Jeffrey W ^c   Schofer, Joachim ^f   Schlüter, Michael ^f   Gershlick, Anthony H ^h   Cohen, Eric A ^b   Palisaitis, Donald A ^a   Breithardt, Günter ^g   Donohoe, Dennis J ^d   Wang, Hong ^d   Popma, Jeffrey J ^e   Kuntz, Richard E ^e   Leon, Martin B ^c  

^a HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^c NewYork Presbyterian Hospital   (United States)

^d JOHNSON AND JOHNSON   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^g UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^h GLENFIELD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; RAPAMYCIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY THROMBOSIS; CORONARY RISK; DOUBLE BLIND PROCEDURE; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART MUSCLE REVASCULARIZATION; HUMAN; INTERMETHOD COMPARISON; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE THROMBOSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; TIME SERIES ANALYSIS;

CORONARY ARTERIOSCLEROSIS; EQUIPMENT DESIGN; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; SIROLIMUS; STENTS; THROMBOSIS; TREATMENT OUTCOME;

EID: 33745180158     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.01.049     Document Type: Article

References (20)

1. Moses J.W., Leon M.B., Popma J.J., Fitzgerald P.J., Holmes D.R., O'Shaughnessy C., Caputo R.P., Kereiakes D.J., William D.O., Teirstein P.A., et al., SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315-1323
2. Stone G.W., Ellis S.G., Cox D.A., Hermiller J., O'Shaughnessy C., Mann J.T., Turco M., Caputo R., Bergin P., Greenberg J., et al., TAXUS-IV Investigators. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350 (2004) 221-231
3. McFadden E.P., Stabile E., Regar E., Cheneau E., Ong A.T.L., Kinnaird T., Suddath W.O., Weissman N.J., Torguson R., Kent K.M., et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 364 (2004) 1519-1521
4. Virmani R., Guagliumi G., and Farb A. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent. Circulation 109 (2004) 701-705
5. Lee C.H., Tan H.C., Ong H.Y., Teo S.G., and Lim Y.T. Late thrombotic occlusion of paclitaxel eluting stent more than one year after stent implantation. Heart 90 (2004) 1482
6. Schofer J., Schlüter M., Gershlick A.H., Wijns W., Garcia E., Schampaert E., Breithardt G., and E-SIRIUS Investigators. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries. double-blind, randomised controlled trial (E-SIRIUS). Lancet 362 (2003) 1093-1099
7. Schampaert E., Cohen E.A., Schlüter M., Reeves F., Traboulsi M., Title L.M., Kuntz R.E., Popma J.J., and C-SIRIUS Investigators. The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). J Am Coll Cardiol 43 (2004) 1110-1115
8. Colombo A., Hall P., Nakamura S., Almagor Y., Maiello L., Martini G., Gaglione A., Goldberg S.L., and Tobis J.M. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation 91 (1995) 1676-1688
9. Cutlip D.E., Baim D.S., Ho K.K.L., Popma J.J., Lansky A.J., Cohen D.J., Carrozza Jr. J.P., Chauhan M.S., Rodriguez O., and Kuntz R.E. Stent thrombosis in the modern era. a pooled analysis of multicenter coronary stent trials. Circulation 103 (2001) 1967-1971
10. Bertrand O.F., Sipehia R., Mongrain R., Rodés J., Tardif J.C., Bilodeau L., Côté G., and Bourassa M.G. Biocompatibility aspects of new stent technology. J Am Coll Cardiol 32 (1998) 562-571
11. Klugherz B.D., Llanos G., Lieuallen W., Kopia G.A., Papandreou G., Narayan P., Sasseen B., Adelman S.J., Falotico R., and Wilensky R.L. Stent-based delivery of sirolimus for the prevention of restenosis. Coron Artery Dis 13 (2002) 183-188
12. Cheneau E., Leborgne L., Mintz G.S., Kotani J.I., Pichard A.D., Satler L.F., Canos D., Castagna M., Weissman N.J., and Waksman R. Predictors of subacute stent thrombosis results of a systematic intravascular ultrasound study. Circulation 108 (2003) 43-47
13. Gurbel P.A., Bliden K.P., Samara W., Yoho J.A., Hayes K., Fissha M.Z., and Tantry U.S. Clopidogrel effect on platelet reactivity in patients with stent thrombosis. results of the CREST Study. J Am Coll Cardiol 46 (2005) 1827-1832
14. Farb A., Burke A.P., and Virmani R. Pathological mechanisms of fatal late stent thrombosis in humans. Circulation 108 (2003) 1701-1706
15. Hayashi T., Kimura A., and Ishikawa K. Acute myocardial infarction caused by thrombotic occlusion at a stent site two years after conventional stent implantation. Heart 90 suppl (2004) e26
16. Guagliumi G., Farb A., Musumeci G., Valsecchi O., Tespili M., Motta T., and Virmani R. Images in cardiovascular medicine. Sirolimus-eluting stent implanted in human coronary artery for 16 months. pathological findings. Circulation 107 (2003) 1340-1341
17. Sousa J.E., Costa M.A., Farb A., Abizaid A., Sousa A., Seixas A.C., da Silva L.M., Feres F., Pinto I., Mattos L.A., et al. Vascular healing 4 years after the implantation of the sirolimus-eluting stent in humans. Circulation 110 suppl (2004) e5-e6
18. Moreno R., Fernández C., Hernández R., Alfonso F., Angiolillo D.J., Sabaté M., Escaned J., Bañuelos C., Fernández-Ortiz A., and Macaya C. Drug eluting stent thrombosis. Results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol 45 (2005) 954-959
19. Iakovou I., Schmidt T., Bonizzoni E., Ge L., Sangiorgi G.M., Stankovic G., Airoldi F., Chieffo A., Montorfano M., Carlino M., et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293 (2005) 2126-2130
20. Ong A.T.L., McFadden E.P., Regar E., de Jaegere P.P.T., van Domburg R.T., and Serruys P.W. Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J Am Coll Cardiol 45 (2005) 2088-2092